Comparative Outcomes of Neo-Adjuvant Chemo-Radiotherapy in Stage II and III Mucinous versus Non-Mucinous Rectal Adenocarcinoma: A Retrospective Study.

Cancer Manag Res · 2025 · PMC12581790 · PMID 41190107

Europe PMC DOI

hedged sentence

0.4000

closest p · 8.0× alpha

0.4000

boldest claim

The sentences

did not reach statistical significanceP = 0.40not close (p > 0.1)

Regarding Neo-CRT, treated patients demonstrated a modest reduction in local recurrence compared to those who did not receive therapy (15% vs 19%), but this difference did not reach statistical significance (P = 0.40), consistent with our OS and CSS results indicating that Neo-CRT was not an independent predictor of survival in this cohort.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.